-
EP4342908
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4342908
| EP4342908 - CHIMERIC IMMUNOGLOBULIN [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 23.02.2024 Database last updated on 09.07.2024 | |
| Former | The international publication has been made Status updated on 23.12.2022 | Most recent event Tooltip | 23.02.2024 | Publication in section I.1 EP Bulletin | published on 27.03.2024 [2024/13] | 23.02.2024 | Request for examination filed | published on 27.03.2024 [2024/13] | Applicant(s) | For all designated states Fapon Biotech Inc. Room 604, 603, 602, 601, Unit ABCD, 6/F Building D2, TCL Science Park, No. 1001 Zhongshan Yuan Road, Liuxiandong, Xili Nanshan District Shenzhen, Guangdong 518000 / CN | [2024/13] | Inventor(s) | 01 /
MENG, Yuan Dongguan, Guangdong 523000 / CN | 02 /
ZHONG, Dongmei Dongguan, Guangdong 523000 / CN | [2024/13] | Representative(s) | V.O. P.O. Box 87930 2508 DH Den Haag / NL | [2024/13] | Application number, filing date | 22823813.5 | 03.03.2022 | [2024/13] | WO2022CN78975 | Priority number, date | CN202110674660 | 17.06.2021 Original published format: CN202110674660 | [2024/13] | Filing language | ZH | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2022262321 | Date: | 22.12.2022 | Language: | ZH | [2022/51] | Type: | A1 Application with search report | No.: | EP4342908 | Date: | 27.03.2024 | Language: | EN | [2024/13] | Search report(s) | International search report - published on: | CN | 22.12.2022 | Classification | IPC: | C07K16/00, C12P21/08 | [2024/13] | CPC: |
C07K16/205 (EP);
C07K16/468 (CN,KR);
C07K16/00 (CN);
C07K16/1003 (EP);
C07K16/18 (EP);
C07K16/40 (EP);
G01N33/54387 (CN,KR);
G01N33/548 (CN);
G01N33/577 (CN,KR);
G01N33/582 (CN);
G01N33/587 (CN);
G01N33/6854 (EP);
C07K2317/24 (EP);
C07K2317/31 (CN,KR);
C07K2317/52 (EP,CN,KR);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2024/13] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | KH | Not yet paid | MA | Not yet paid | MD | Not yet paid | TN | Not yet paid | Title | German: | CHIMERES IMMUNGLOBULIN | [2024/13] | English: | CHIMERIC IMMUNOGLOBULIN | [2024/13] | French: | IMMUNOGLOBULINE CHIMÉRIQUE | [2024/13] | Entry into regional phase | 20.12.2023 | Translation filed | 20.12.2023 | National basic fee paid | 20.12.2023 | Search fee paid | 20.12.2023 | Designation fee(s) paid | 20.12.2023 | Examination fee paid | Examination procedure | 20.12.2023 | Amendment by applicant (claims and/or description) | 20.12.2023 | Examination requested [2024/13] | Fees paid | Renewal fee | 20.12.2023 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]CN101980603 (BIOGEN IDEC INC); | [A]CN102643344 (TRUBION PHARMACEUTICALS INC); | [A]CN106029694 (DANA FARBER CANCER INST INC); | by applicant | CN111018983 | CN111349168 | CN111363044 | CN112239501 | CN112239500 |